Plasma IL‐6 levels were identified as an independent prognostic factor in another cohort of advanced HCC patients (n = 64) treated with chemoIO and αPD‐L1, with high IL‐6 portending shorter PFS and OS.31 This evidence concerns the gene IL6 and hepatocellular carcinoma.